Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Boswell

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Investigative Ophthalmology & Visual Science|October 30, 2015
Evaluation of Fluorophotometry to Assess the Vitreal Pharmacokinetics of Protein TherapeuticsLeslie J Dickmann, Victor Yip, Cuiwen Li, et al.
Journal of Medicinal Chemistry|January 11, 2002
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligandsXiankai Sun, Melinda Wuest, Gary R Weisman, et al.
Journal of Pharmaceutical Sciences|September 10, 2020
Balancing the Affinity and Pharmacokinetics of Antibodies by Modulating the Size of Charge Patches on Complementarity-Determining RegionsYue Sun, Hao Cai, Zhilan Hu, et al.
Pharmaceutics|January 28, 2026
Correction: Susilo et al. Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies. <i>Pharmaceutics</i> 2025, <i>17</i>, 500Monica E Susilo, Stephan Schaller, Luis David Jiménez-Franco, et al.
Bioconjugate Chemistry|August 11, 2025
Effects of Pretargeting and FcRn Binding Abrogation on the Biodistribution of a One-Armed Antibody-Based T Cell Imaging AgentDanielle Mandikian, Lauren Sermeño, Rachana Ohri, et al.
Pharmaceutics|April 26, 2025
Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific AntibodiesMonica E Susilo, Stephan Schaller, Luis David Jiménez-Franco, et al.
The AAPS Journal|October 10, 2018
Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational PharmacologyDanielle Mandikian, Isabel Figueroa, Amy Oldendorp, et al.
Molecular Pharmaceutics|April 8, 2014
Comparative physiology of mice and rats: radiometric measurement of vascular parameters in rodent tissuesC Andrew Boswell, Eduardo E Mundo, Sheila Ulufatu, et al.
Mabs|February 27, 2016
Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitorRong Deng, Daniela Bumbaca, Cinthia V Pastuskovas, et al.
Bioconjugate Chemistry|July 4, 2008
Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabelingC Andrew Boswell, Celeste A S Regino, Kwamena E Baidoo, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Investigative Ophthalmology & Visual Science|October 30, 2015
Evaluation of Fluorophotometry to Assess the Vitreal Pharmacokinetics of Protein TherapeuticsLeslie J Dickmann, Victor Yip, Cuiwen Li, et al.
Journal of Medicinal Chemistry|January 11, 2002
Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligandsXiankai Sun, Melinda Wuest, Gary R Weisman, et al.
Journal of Pharmaceutical Sciences|September 10, 2020
Balancing the Affinity and Pharmacokinetics of Antibodies by Modulating the Size of Charge Patches on Complementarity-Determining RegionsYue Sun, Hao Cai, Zhilan Hu, et al.
Pharmaceutics|January 28, 2026
Correction: Susilo et al. Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies. <i>Pharmaceutics</i> 2025, <i>17</i>, 500Monica E Susilo, Stephan Schaller, Luis David Jiménez-Franco, et al.
Bioconjugate Chemistry|August 11, 2025
Effects of Pretargeting and FcRn Binding Abrogation on the Biodistribution of a One-Armed Antibody-Based T Cell Imaging AgentDanielle Mandikian, Lauren Sermeño, Rachana Ohri, et al.
Pharmaceutics|April 26, 2025
Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific AntibodiesMonica E Susilo, Stephan Schaller, Luis David Jiménez-Franco, et al.
The AAPS Journal|October 10, 2018
Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational PharmacologyDanielle Mandikian, Isabel Figueroa, Amy Oldendorp, et al.
Molecular Pharmaceutics|April 8, 2014
Comparative physiology of mice and rats: radiometric measurement of vascular parameters in rodent tissuesC Andrew Boswell, Eduardo E Mundo, Sheila Ulufatu, et al.
Mabs|February 27, 2016
Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitorRong Deng, Daniela Bumbaca, Cinthia V Pastuskovas, et al.
Bioconjugate Chemistry|July 4, 2008
Synthesis of a cross-bridged cyclam derivative for peptide conjugation and 64Cu radiolabelingC Andrew Boswell, Celeste A S Regino, Kwamena E Baidoo, et al.
Pageof 7